Traders worry vaccine complacency is the new risk to the market

UBS's Art Cashin believes the market may be far too complacent in believing that a highly effective vaccine is imminent.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.